Items where authors include "Appelt, AL"

Article

Murray, LJ orcid.org/0000-0003-0658-6455, Appelt, AL, Ajithkumar, T et al. (9 more authors) (2023) Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the Market. Clinical Oncology, 35 (5). pp. 318-322. ISSN 0936-6555

Theophanous, S orcid.org/0000-0002-4148-3905, Lønne, P-I, Choudhury, A et al. (25 more authors) (2022) Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study. Diagnostic and Prognostic Research, 6 (1). 14. p. 14. ISSN 2397-7523

Theophanous, S, Samuel, R, Lilley, J et al. (4 more authors) (2022) Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review. BMC Cancer, 22 (1). 607. ISSN 1471-2407

Van Limbergen, EJ, Hazelaar, C, Vaassen, F et al. (11 more authors) (2022) Endorectal contact radiation boosting: Making the case for dose AND volume reporting. Brachytherapy, 21 (6). pp. 887-895. ISSN 1538-4721

Andratschke, N, Willmann, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Hudson, EM orcid.org/0000-0001-8758-7163, Noutch, S, Brown, S orcid.org/0000-0002-7975-7537 et al. (19 more authors) (2022) A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. BMJ Open, 12 (4). e049119. ISSN 2044-6055

Stewart, AJ, Van Limbergen, EJ, Gerard, J-P et al. (7 more authors) (2022) GEC ESTRO ACROP Consensus recommendations for contact brachytherapy for rectal cancer. Clinical and Translational Radiation Oncology, 33. pp. 15-22. ISSN 2405-6308

Appelt, AL orcid.org/0000-0003-2792-9218, Elhaminia, B, Gooya, A et al. (2 more authors) (2022) Deep Learning for Radiotherapy Outcome Prediction Using Dose Data – A Review. Clinical Oncology, 34 (2). e87-e96. ISSN 0936-6555

Nix, M, Gregory, S, Aldred, M et al. (8 more authors) (2022) Dose summation and image registration strategies for radiobiologically and anatomically corrected dose accumulation in pelvic re-irradiation. Acta Oncologica, 61 (1). pp. 64-72. ISSN 0284-186X

Rønde, HS, Kallehauge, JF, Kronborg, CJS et al. (6 more authors) (2021) Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation. Acta Oncologica, 60 (11). pp. 1436-1439. ISSN 0284-186X

Espensen, CA, Kiilgaard, JF, Klemp, K et al. (3 more authors) (2021) 3D image‐guided treatment planning for Ruthenium‐106 brachytherapy of choroidal melanomas. Acta Ophthalmologica, 99 (5). e654-e660. ISSN 1755-375X

Choudhury, A, Theophanous, S orcid.org/0000-0002-4148-3905, Lønne, P-I et al. (11 more authors) (2021) Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - a proof-of-concept study. Radiotherapy and Oncology, 159. pp. 183-189. ISSN 0167-8140

Webster, A, Appelt, AL orcid.org/0000-0003-2792-9218 and Eminowicz, G (2020) Image-Guided Radiotherapy for Pelvic Cancers: A Review of Current Evidence and Clinical Utilisation. Clinical Oncology, 32 (12). pp. 805-816. ISSN 0936-6555

Couwenberg, AM, Burbach, JPM, Berbee, M et al. (18 more authors) (2020) Efficacy of dose-escalated chemoradiation on complete tumour response in patients with locally advanced rectal cancer (RECTAL-BOOST); a phase 2 randomised controlled trial. International Journal of Radiation: Oncology - Biology - Physics, 108 (4). pp. 1008-1018. ISSN 0360-3016

Espensen, CA, Kiilgaard, JF, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (5 more authors) (2020) Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas. Ophthalmology. ISSN 0161-6420

Peters, FP, Teo, MTW, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (7 more authors) (2020) Mesorectal radiotherapy for early stage rectal cancer: A novel target volume. Clinical and Translational Radiation Oncology, 21. pp. 104-111. ISSN 2405-6308

Appelt, AL orcid.org/0000-0003-2792-9218, Andersen, RF, Lindebjerg, J et al. (1 more author) (2020) Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial. American Journal of Clinical Oncology, 43 (1). pp. 9-13. ISSN 0277-3732

Espensen, CA, Appelt, AL orcid.org/0000-0003-2792-9218, Fog, LS et al. (4 more authors) (2020) Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas. Acta Oncologica, 59 (8). pp. 918-925. ISSN 0284-186X

Scherman, J, Appelt, AL orcid.org/0000-0003-2792-9218, Yu, J et al. (5 more authors) (2019) Incorporating NTCP into randomized trials of proton versus photon therapy. International Journal of Particle Therapy, 5 (3). pp. 24-32.

Brown, PJ, Zhong, J, Frood, R orcid.org/0000-0003-2681-9922 et al. (5 more authors) (2019) Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT. European Journal of Nuclear Medicine and Molecular Imaging, 46 (13). pp. 2790-2799. ISSN 1619-7070

Appelt, AL orcid.org/0000-0003-2792-9218, Kerkhof, EM, Nyvang, L et al. (8 more authors) (2019) Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study. Technical Innovations & Patient Support in Radiation Oncology, 11. pp. 14-21. ISSN 2405-6324

Christophides, D, Appelt, AL orcid.org/0000-0003-2792-9218, Gusnanto, A et al. (2 more authors) (2018) Method for Automatic Selection of Parameters in Normal Tissue Complication Probability Modeling. International Journal of Radiation Oncology Biology Physics, 101 (3). pp. 704-712. ISSN 0360-3016

Kovacs, DG, Rechner, LA, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (7 more authors) (2018) Metal artefact reduction for accurate tumour delineation in radiotherapy. Radiotherapy and Oncology, 126 (3). pp. 479-486. ISSN 0167-8140

Teo, MTW, McParland, L, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (1 more author) (2018) Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review. International Journal of Radiation Oncology Biology Physics, 100 (1). pp. 146-158. ISSN 0360-3016

Rønde, HS, Wee, L, Pløen, J et al. (1 more author) (2017) Feasibility of preference-driven radiotherapy dose treatment planning to support shared decision making in anal cancer. Acta Oncologica, 56 (10). pp. 1277-1285. ISSN 0284-186X

Espensen, CA, Jensen, PK, Fog, LS et al. (5 more authors) (2017) Ultrasonic mirror image from ruthenium plaque facilitates calculation of uveal melanoma treatment dose. British Journal of Ophthalmology, 101 (9). pp. 1206-1210. ISSN 0007-1161

Moller, DS, Nielsen, TB, Brink, C et al. (14 more authors) (2017) Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study. Radiotherapy and Oncology, 124 (2). pp. 311-317. ISSN 0167-8140

Thomsen, CE, Appelt, AL orcid.org/0000-0003-2792-9218, Andersen, RF et al. (3 more authors) (2017) The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer. Cancer Medicine, 6 (5). pp. 928-936.

Mortensen, MS, Lauritsen, J, Kier, MGG et al. (7 more authors) (2016) Late Relapses in Stage I Testicular Cancer Patients on Surveillance. European Urology, 70 (2). pp. 365-371. ISSN 0302-2838

Appelt, AL orcid.org/0000-0003-2792-9218 and Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 (2016) Technological advances in radiotherapy of rectal cancer: opportunities and challenges. Current Opinion in Oncology, 28 (4). pp. 353-358. ISSN 1040-8746

Eriksen, AHM, Andersen, RF, Nielsen, BS et al. (4 more authors) (2016) Intratumoral heterogeneity of microRNA expression in rectal cancer. PLoS ONE, 11 (6). ISSN 1932-6203

Appelt, AL orcid.org/0000-0003-2792-9218, Pløen, J, Harling, H et al. (6 more authors) (2015) High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. The Lancet Oncology, 16 (8). pp. 919-927. ISSN 1470-2045

Proceedings Paper

Bach, SP, De Wilt, JHW, Peters, F et al. (18 more authors) (2022) STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer? In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting I, 02-07 Jun 2022, Chicago, IL, USA. American Society of Clinical Oncology .

Dizdarevic, E, Appelt, AL orcid.org/0000-0003-2792-9218, Hansen, T et al. (5 more authors) (2019) Long-term outcomes after high-dose chemoradiotherapy for non-surgical management of distal rectal cancer. In: Journal of Clinical Oncology. 55th Annual Meeting of the American Society of Clinical Oncology (ASCO 2019), 31 May - 04 Jun 2019, Chicago, IL, USA. American Society of Clinical Oncology .

Persson, G, Schytte, T, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2019) Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier , S739-S740.

Appelt, AL orcid.org/0000-0003-2792-9218 (2019) The vital role of physicists in clinical trials: from design to data analysis. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier , S233-S233.

Appelt, AL orcid.org/0000-0003-2792-9218, Andersen, RF, Lindebjerg, J et al. (1 more author) (2018) OC-0283: Prognostic value of serum NPY hypermethylation in neoadjuvant chemoradiotherapy for rectal cancer. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S145-S146.

Appelt, AL orcid.org/0000-0003-2792-9218, Havelund, BM, Rønde, HS et al. (3 more authors) (2018) PO-0798: High dose IMRT for locally advanced rectal cancer – late toxicity and patient-reported outcomes. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S413-S415.

Hemer, M, Gram, V, Aznar, MC et al. (4 more authors) (2018) PV-0369: Tiredness, pain and quality of life for patients receiving RT for spinal cord compression. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S189-S189.

Murray, L, Speight, R, Dickinson, P et al. (4 more authors) (2018) PV-0474: Pelvic re-irradiation with Stereotactic Ablative Radiotherapy (SABR): outcomes and cumulative doses. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S243-S244.

Appelt, AL orcid.org/0000-0003-2792-9218 (2018) SP-0232: Dose escalation for non-surgical management. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S121-S122.

Espensen, CA, Thariat, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (6 more authors) (2017) NTCP-based prediction of maculopathy after proton therapy or Ruthenium-106 brachytherapy for choroidal melanomas. In: Investigative Opthalmology & Visual Science. 2017 ARVO Annual Meeting, 07-11 May 2017, Baltimore, Md, USA. Association for Research in Vision and Opthalmology .

Appelt, AL orcid.org/0000-0003-2792-9218, Teo, M, Christophides, D et al. (5 more authors) (2017) EP-1748: Mesorectal-only irradiation for early stage rectal cancer: Target volumes and dose to organs at risk. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S962-S963.

Christophides, D, Gilbert, A, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (3 more authors) (2017) OC-0255: Practical use of principal component analysis in radiotherapy planning. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S129-S130.

Christophides, D, Appelt, AL orcid.org/0000-0003-2792-9218, Lilley, J et al. (1 more author) (2017) PO-0853: A method for automatic selection of parameters in NTCP modelling. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S463-S464.

Guren, MG, Christensen, HK, Larsen, SG et al. (3 more authors) (2016) Re-RAD-I external beam radiotherapy for pelvic recurrences in rectal cancer patients previously treated with radiotherapy. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016. Oxford University Press .

Thomsen, CB, Appelt, AL orcid.org/0000-0003-2792-9218, Andersen, RF et al. (3 more authors) (2016) The prognostic impact of RAS and RAF serum mutations in localized colon cancer. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016, Copenhagen, Denmark. Oxford University Press .

Appelt, AL orcid.org/0000-0003-2792-9218, Bentzen, SM and Vogelius, IR (2016) EP-1724: Model-based effect estimates reduce sample-size requirements in randomized trials of proton therapy. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S806-S807.

Nielsen, TB, Brink, C, Moeller, DS et al. (10 more authors) (2016) EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S916-S917.

Rønde, HS, Pløen, J, Wee, L et al. (1 more author) (2016) OC-0472: Patient preference-driven plan optimisation for shared decision making in anal cancer radiotherapy. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S224-S225.

Moeller, DS, Hoffmann, L, Lutz, CM et al. (10 more authors) (2016) OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2019, Turin, Italy. Elsevier , S259-S259.